Alpiniae Oxyphyllae Fructus-Saposhnikoviae Radix regulates NLRP3 inflammasome to ameliorate inflammatory response in diabetic kidney disease mice through PI3K/Akt/mTOR signaling pathway.
10.19540/j.cnki.cjcmm.20250214.502
- Author:
Zi-Jie YAN
1
;
Lin ZHANG
2
;
Xin-Yao HAN
3
;
Tian-Peng MA
2
;
Song-Jing ZHOU
4
Author Information
1. College of Traditional Chinese Medicine, Hainan Medical University Haikou 571199, China Sanya Traditional Chinese Medicine Hospital Sanya 572000, China.
2. College of Traditional Chinese Medicine, Hainan Medical University Haikou 571199, China.
3. the First Clinical Medical College of Guizhou University of Traditional Chinese Medicine Guiyang 550002, China.
4. Hainan General Hospital Haikou 571199, China.
- Publication Type:Journal Article
- Keywords:
Alpiniae Oxyphyllae Fructus-Saposhnikoviae Radix;
NLRP3 inflammasome;
PI3K/Akt/mTOR signaling pathway;
diabetic kidney disease;
inflammation;
network pharmacology;
traditional Chinese medicine
- MeSH:
Animals;
Mice;
NLR Family, Pyrin Domain-Containing 3 Protein/metabolism*;
Signal Transduction/drug effects*;
Phosphatidylinositol 3-Kinases/metabolism*;
Proto-Oncogene Proteins c-akt/metabolism*;
TOR Serine-Threonine Kinases/metabolism*;
Diabetic Nephropathies/metabolism*;
Inflammasomes/drug effects*;
Male;
Drugs, Chinese Herbal/chemistry*;
Humans;
Mice, Inbred C57BL
- From:
China Journal of Chinese Materia Medica
2025;50(10):2798-2809
- CountryChina
- Language:Chinese
-
Abstract:
This study aims to evaluate the therapeutic effect of Alpiniae Oxyphyllae Fructus-Saposhnikoviae Radix(AOF-SR) in a diabetic kidney disease(DKD) mouse model, explore its potential mechanism in regulating the NOD-like receptor protein 3(NLRP3) inflammasome via phosphoinositide 3-kinase(PI3K)/protein kinase B(Akt)/mammalian target of rapamycin(mTOR) signaling pathway, and provide new theoretical support for traditional Chinese medicine(TCM) intervention in DKD. Using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP), the active ingredients and potential targets of AOF-SR were screened and its molecular mechanisms were investigated through molecular docking, molecular dynamics simulations, and experimental validation. The db/db mice were randomly divided into four groups: model group, low-dose AOF-SR group, high-dose AOF-SR group, and canagliflozin group. The db/m mice served as normal group. After one week of acclimatization, the mice underwent drug intervention. Starting from one week after treatment, body weight, blood glucose levels, and 24-hour urinary protein(24hUP) were measured every two weeks. After 13 weeks of administration, tissue collection and indicator detection were performed. Blood glucose, 24hUP, urinary microalbumin(mAlb), serum creatinine(Scr), and blood urea nitrogen(BUN) levels were determined. Pathological changes in kidney tissue were observed using hematoxylin-eosin(HE) staining. Enzyme-linked immunosorbent assay(ELISA) was used to detect the levels of serum IL-1β, IL-18, and caspase-1, while RT-qPCR was employed to measure the mRNA expression levels of IL-1β, IL-18, caspase-1, and NLRP3. Western blot was used to assess the protein expression levels of NLRP3, PI3K, p-Akt, Akt, p-mTOR, and mTOR. Network pharmacology analysis indicated that wogonin, pinocembrin, hancinol, and kaempferol were the core compounds for drug treatment of the disease. Molecular docking and molecular dynamics simulations showed that core compounds, particularly wogonin, could specifically bind to PIK3R1, thereby regulating the PI3K/Akt/mTOR pathway. The experimental results indicated that both low and high doses of AOF-SR and canagliflozin significantly reduced blood glucose, 24hUP, mAlb, Scr, and BUN levels in db/db mice, while improving kidney pathological damage and inflammatory cell infiltration. Moreover, the treatments reduced the mRNA expression levels of caspase-1, IL-1β, and IL-18 in the kidneys of db/db mice, as well as the secretion of these factors in the serum. The drugs also inhibited the mRNA and protein expression levels of NLRP3 in the kidneys of db/db mice and decreased the protein levels of PI3K, p-Akt/Akt, and p-mTOR/mTOR. In conclusion, AOF-SR may improve kidney inflammation in DKD mice by regulating the PI3K/Akt/mTOR signaling pathway and inhibiting NLRP3 inflammasome activation.
